MALESCI, Alberto Carlo Piero

MALESCI, Alberto Carlo Piero  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 241 (tempo di esecuzione: 0.044 secondi).
Titolo Data di pubblicazione Autore(i) File
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 1-gen-2010 Fiorino, G.; Bonifacio, C.; Minuti, F.; Repici, A.; Spinelli, A.; Fries, W.; Malesci, A.; Balzarini, L.; Danese, S.
Abdominal cocoon or idiopathic encapsulating peritoneal sclerosis : magnetic resonance imaging 1-gen-2014 Jovani, M.; Baticci, F.; Bonifacio, C.; Omodei, P. D.; Malesci, A.
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine 1-gen-1996 Savarino, V.; Mela, G. S.; Zentilin, P.; Cutela, P.; Vigneri, S.; Termini, R.; Di Mario, F.; Ferrana, M.; Malesci, A.; Belicchi, M.; Celle, G.
Achalasia with dense eosinophilic infiltrate responds to steroidal therapy 1-gen-2011 Savarino, E.; Gemignani, L.; Zentilin, P.; De Bortoli, N.; Malesci, A.; Mastracci, L.; Fiocca, R.; Savarino, V.
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 1-gen-2019 Tacconi, C; Ungaro, F; Correale, C; Arena, V; Massimino, L; Detmar, M; Spinelli, A; Carvello, M; Mazzone, M; Oliveira, Ai; Rubbino, F; Garlatti, V; Spanò, S; Lugli, E; Colombo, Fs; Malesci, A; Peyrin-Biroulet, L; Vetrano, S; Danese, S; D'Alessio, S
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 1-gen-2011 Fiorino, G.; Szabò, H.; Walter, F.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S.
Adalimumab in ulcerative colitis: hypes and hopes 1-gen-2011 Fiorino, G.; Peyrin-Biroulet, L.; Repici, A.; Malesci, A.
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 1-gen-2010 Fiorino, G.; Repici, A.; Malesci, A.; Danese, S.
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease 1-gen-2011 Savarino, Edoardo; Marabotto, Elisa; Zentilin, Patrizia; Frazzoni, Marzio; Sammito, Giorgio; Bonfanti, Daria; Sconfienza, Luca; Assandri, Lorenzo; Gemignani, Lorenzo; Malesci, Alberto Carlo Piero; Savarino, Vincenzo
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 1-gen-2008 Stefanelli, T.; Malesci, A.; De La Rue, S. A.; Danese, S.
Autonomic nervous system dysregulation in irritable bowel syndrome 1-gen-2015 Salvioli, B.; Pellegatta, G.; Malacarne, M.; Pace, F.; Malesci, A.; Pagani, M.; Lucini, D.
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 1-gen-2010 Correale, C; Martinoli, C; Vetrano, S; Mazzini, E; Caprioli, F; Spinelli, A; Arena, V; Fiorino, G; Passini, N; Panina, P; Repici, A; Malesci, A; Rescigno, M; Danese, S
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 1-gen-2013 Correale, C.; Genua, M.; Vetrano, S.; Mazzini, E.; Martinoli, C.; Spinelli, A.; Arena, V.; Peyrin Biroulet, L.; Caprioli, F.; Passini, N.; Panina Bordignon, P.; Repici, A.; Malesci, A.; Rutella, S.; Rescigno, M.; Danese, S.
Balanced poropofol sedation in patients undergoing EUS-FNA: a pilot study to assess feasibility and safety 1-gen-2011 Pagano, N.; Arosio, M.; Romeo, F.; Rando, G.; Del Conte, G.; Carlino, A.; Strangio, G.; Vitetta, E.; Malesci, A.; Repici, A.
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 1-gen-2010 Repici, A; Fiorino, G; Pagano, N; Romeo, F; Carlino, A; Arosio, M; Strangio, G; Rando, G; Ferreira, Dp; Malesci, A; Danese, S
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 1-gen-2011 Repici, A.; Pagano, N.; Hassan, C.; Carlino, A.; Rando, G.; Strangio, G.; Romeo, F.; Zullo, A.; Ferrara, E.; Vitetta, E.; de Paula Pessoa Ferreira, D.; Danese, S.; Arosio, M.; Malesci, A.
Biological agents for ulcerative colitis : Hypes and hopes 1-gen-2008 Danese, S.; Angelucci, E.; Malesci, A.; Caprilli, R.
THE BNX SYSTEM: PRELIMINARY DATA FROM THE FIRST ITALIAN EXPERIENCE WITH A NEW NEEDLE DEVICE FOR EUS-GUIDED FNA: A RANDOMIZED CLINICAL TRIAL COMPARING THE 25G AND 22G NEEDLE IN THE EUS-FNA OF SOLID LESIONS 1-gen-2014 Carrara, S; Anderloni, A; Jovani, M; Di Tomasso, L; Davide, F; Repici, A; Malesci, A
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 1-gen-2015 Fiorino, G.; Bonifacio, C.; Allocca, M.; Repici, A.; Balzarini, L.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S.
Brain cholecystokinin depletion in rats with acute liver failure 1-gen-1989 Bonato, C.; Malesci, A.; Rosati, R.; Vignati, F.; Montorsi, M.; Bersani, M.; Abbiati, R.; Salerno, F.